Skip to main content
SpringerLink
Log in

The first case of a patient with neutropenia and giant-cell arteritis treated with rituximab

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH et al (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778–799

    Article  PubMed  CAS  Google Scholar 

  2. Weyand CM, Goronzy JJ (2003) Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 139:505–515

    PubMed  Google Scholar 

  3. van der Veen MJ, Dinant HJ, van Booma-Frankfort C, van Albada-Kuipers GA, Bijlsam JW (1996) Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? Ann rheum Dis 55:218–223

    Article  PubMed  Google Scholar 

  4. Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B (2001) Combined treatment of giant-cell arteritis with methotrexat and prednisone. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 134:106–114

    PubMed  CAS  Google Scholar 

  5. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM (2001) T cell activation in rheumatoid synovium is B cell dependent. J Immunol 167:4710–4718

    PubMed  CAS  Google Scholar 

  6. Dorner T, Burmester GR (2003) The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets. Curr Opin Rheumatol 15:246–252

    Article  PubMed  Google Scholar 

  7. Edwards JCW, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T (2004) Efficacy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis. N Eng J Med 350:2572–2581

    Article  CAS  Google Scholar 

  8. Bhatia A, Ell PJ, Edwards JCW (2005) Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis. Ann Rheum Dis 64:1099–1100

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fourth Department of Internal Medicine, General Hospital, Grieskirchnerstrasse 42, 4600, Wels, Austria

    B. Mayrbaeurl, S. Burgstaller, M. Windpessl & J. Thaler

  2. First Department of Internal Medicine, General Hospital, Grieskirchnerstrasse 42, 4600, Wels, Austria

    M. Hinterreiter

Authors
  1. B. Mayrbaeurl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Hinterreiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Burgstaller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Windpessl
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Thaler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Mayrbaeurl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mayrbaeurl, B., Hinterreiter, M., Burgstaller, S. et al. The first case of a patient with neutropenia and giant-cell arteritis treated with rituximab. Clin Rheumatol 26, 1597–1598 (2007). https://doi.org/10.1007/s10067-007-0684-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-007-0684-0

Keywords

Search

Navigation